Skip to main content

Table 3 The percentage of treatment response and depression remission in Sham and PMES groups

From: Percutaneous mastoid electrical stimulator improves Poststroke depression and cognitive function in patients with Ischaemic stroke: a prospective, randomized, double-blind, and sham-controlled study

 

Sham group(133)

PMES group(125)

OR(95%CI)

P*

Treatment response, n(%)

55 (41.35%)

72 (57.60%)

1.93 (1.18–3.16)

0.009

Depression remission, n(%)

39 (29.32%)

55 (44.00%)

1.89 (1.13–3.17)

0.014

  1. Bold indicates P-values less than 0.05
  2. *Continuous variables are expressed as mean ± standard deviation. Mann-Whitney U test was used to test differences between two groups. Categorical data were described using frequency and percentage, using Pearson χ2 test, Fisher exact 2-sided test
Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us